Sherbrooke Park Advisers LLC Aurinia Pharmaceuticals Inc. Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q1 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 31,021 shares of AUPH stock, worth $250,339. This represents 0.12% of its overall portfolio holdings.
Number of Shares
31,021Holding current value
$250,339% of portfolio
0.12%Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
239Shares Held
64.9MCall Options Held
1.1MPut Options Held
772K-
Tang Capital Management LLC San Diego, CA10MShares$80.9 Million5.24% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$74.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5MShares$40.4 Million0.61% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32 Million3.03% of portfolio
-
State Street Corp Boston, MA2.85MShares$23 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.15B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...